Clinical Trial

A Post-Market Assessment of the Safety and Performance of the TriClip™ System

Study acronym: TREAT TR
Recruiting
View on ClinicalTrials.gov →
Summary
The objective of the TREAT TR study is to confirm the safety and performance of the TriClip System for tricuspid TEER in a contemporary, real-world setting, using the commercially available device in accordance with its approved indications for use.
Protocol Amendment History 2 changes
critical Trial status changed: Enrolling by Invitation → Recruiting 2026-07-03
critical Primary endpoint(s) modified 2026-07-03
Trial Details
NCT Number NCT07586995
Lead Sponsor Abbott Medical Devices
Conditions Tricuspid Regurgitation (TR)
Enrollment 1,000 participants
Start Date 2026-07-02
Primary Completion 2028-09 (estimated)
Study Completion 2033-08 (estimated)
Updated on ClinicalTrials.gov 2026-08-03